FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064753657> ?p ?o ?g. }

• W2064753657 abstract "Background: Numerous retrospective analyses of prospective randomized clinical trials of patients treated with adjuvant tamoxifen and chemotherapy have demonstrated that the breast cancer intrinsic subtype Luminal A tumors generally have favorable early initial outcomes, while basal-like tumors are associated with a marked risk of early relapse. To determine the extended natural history of the intrinsic subtypes across two decades of follow up the PAM50 “non-commercial open source bioinformatics” qPCR assay was conducted on node negative tumors accrued through the Cooperative Breast Cancer Tissue Registry (CBCTR) from patients who did not receive systemic therapy. Methods: Intrinsic subtype calls were obtained from 331 CBCTR cases treated with local interventions only. Tumors were classified into Luminal A (LumA), Luminal B (LumB), HER2-enriched (HER2-E) and Basal-like (BLBC), and correlated relapse-free (RFS). Patient survival and hazard rate were estimated using Kaplan-Meier plots and log-rank test. Multivariable Cox regression analyses were used to determine the significance of the intrinsic subtypes, adjusted with standard clinicopathological variables including tumor size, age at diagnosis, grade, radiation therapy treatment, centralized reviewed estrogen receptor, progesterone receptor and human epidermal growth factor 2 status measured by immunohistochemistry. Patients were diagnosed from 1978 to 1992, with a mean follow-up time of 13 years (range 0.5–31). Results: Of the 331 tumors tested, 51% of cases were classified as LumA, 18% as LumB, 11% as HER2-E and 20% as BLBC. Although LumA was associated with the best outcome for the first 10-year of follow-up, the final number of RFS events were eventually comparable with those observed for BLBC with prolonged follow up (Table 1). In the multivariable Cox model, only BLBC tumors were associated with worse prognosis than LumA with borderline significance (Hazard ratio: 2.0 (95% CI 0.9–5), p = 0.07). BLBC had the highest hazard rates for the first 5 years (7% at first year to 5% at 5 yr), consistent with previous observations. Interestingly, in the absence of treatment, the slow growing LumA subtype had a gradual increase of hazard for an RFS event from 3% at 5 yrs to 4% at 10 yrs to 7% at 20 yrs. The hazard rates of LumA cross with those of BLBC at 10 years. Conclusions: Basal-like breast cancers are associated with an early risk of relapse that decreases over time. In contrast, Luminal A breast cancer has a low risk of relapse at the outset but the risk of relapse increases over time and is responsible of the majority of the RFS events after 20 years of follow up. Luminal A breast cancers are therefore not truly low risk, particularly if they do not receive endocrine therapy; and may experience the consequences of inadequate treatment decades after diagnosis. Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-07-10." @default.
• W2064753657 created "2016-06-24" @default.
• W2064753657 creator A5006339912 @default.
• W2064753657 creator A5006639549 @default.
• W2064753657 creator A5018385233 @default.
• W2064753657 creator A5019349196 @default.
• W2064753657 creator A5027691610 @default.
• W2064753657 creator A5027714983 @default.
• W2064753657 creator A5032078333 @default.
• W2064753657 creator A5033142370 @default.
• W2064753657 creator A5035228577 @default.
• W2064753657 creator A5041451628 @default.
• W2064753657 creator A5054642128 @default.
• W2064753657 creator A5068704607 @default.
• W2064753657 creator A5071738043 @default.
• W2064753657 creator A5076031555 @default.
• W2064753657 creator A5085574030 @default.
• W2064753657 creator A5089513581 @default.
• W2064753657 creator A5091758093 @default.
• W2064753657 date "2012-12-15" @default.
• W2064753657 modified "2023-09-27" @default.
• W2064753657 title "Abstract P6-07-10: Luminal A vs. Basal-like Breast Cancer: time dependent changes in the risk of relapse in the absence of treatment" @default.
• W2064753657 doi "https://doi.org/10.1158/0008-5472.sabcs12-p6-07-10" @default.
• W2064753657 hasPublicationYear "2012" @default.
• W2064753657 type Work @default.
• W2064753657 sameAs 2064753657 @default.
• W2064753657 citedByCount "0" @default.
• W2064753657 crossrefType "proceedings-article" @default.
• W2064753657 hasAuthorship W2064753657A5006339912 @default.
• W2064753657 hasAuthorship W2064753657A5006639549 @default.
• W2064753657 hasAuthorship W2064753657A5018385233 @default.
• W2064753657 hasAuthorship W2064753657A5019349196 @default.
• W2064753657 hasAuthorship W2064753657A5027691610 @default.
• W2064753657 hasAuthorship W2064753657A5027714983 @default.
• W2064753657 hasAuthorship W2064753657A5032078333 @default.
• W2064753657 hasAuthorship W2064753657A5033142370 @default.
• W2064753657 hasAuthorship W2064753657A5035228577 @default.
• W2064753657 hasAuthorship W2064753657A5041451628 @default.
• W2064753657 hasAuthorship W2064753657A5054642128 @default.
• W2064753657 hasAuthorship W2064753657A5068704607 @default.
• W2064753657 hasAuthorship W2064753657A5071738043 @default.
• W2064753657 hasAuthorship W2064753657A5076031555 @default.
• W2064753657 hasAuthorship W2064753657A5085574030 @default.
• W2064753657 hasAuthorship W2064753657A5089513581 @default.
• W2064753657 hasAuthorship W2064753657A5091758093 @default.
• W2064753657 hasConcept C121608353 @default.
• W2064753657 hasConcept C126322002 @default.
• W2064753657 hasConcept C143998085 @default.
• W2064753657 hasConcept C188816634 @default.
• W2064753657 hasConcept C207103383 @default.
• W2064753657 hasConcept C2777176818 @default.
• W2064753657 hasConcept C2777982462 @default.
• W2064753657 hasConcept C2778024521 @default.
• W2064753657 hasConcept C2779306644 @default.
• W2064753657 hasConcept C29456083 @default.
• W2064753657 hasConcept C44249647 @default.
• W2064753657 hasConcept C50382708 @default.
• W2064753657 hasConcept C530470458 @default.
• W2064753657 hasConcept C71924100 @default.
• W2064753657 hasConcept C84606932 @default.
• W2064753657 hasConcept C98717036 @default.
• W2064753657 hasConceptScore W2064753657C121608353 @default.
• W2064753657 hasConceptScore W2064753657C126322002 @default.
• W2064753657 hasConceptScore W2064753657C143998085 @default.
• W2064753657 hasConceptScore W2064753657C188816634 @default.
• W2064753657 hasConceptScore W2064753657C207103383 @default.
• W2064753657 hasConceptScore W2064753657C2777176818 @default.
• W2064753657 hasConceptScore W2064753657C2777982462 @default.
• W2064753657 hasConceptScore W2064753657C2778024521 @default.
• W2064753657 hasConceptScore W2064753657C2779306644 @default.
• W2064753657 hasConceptScore W2064753657C29456083 @default.
• W2064753657 hasConceptScore W2064753657C44249647 @default.
• W2064753657 hasConceptScore W2064753657C50382708 @default.
• W2064753657 hasConceptScore W2064753657C530470458 @default.
• W2064753657 hasConceptScore W2064753657C71924100 @default.
• W2064753657 hasConceptScore W2064753657C84606932 @default.
• W2064753657 hasConceptScore W2064753657C98717036 @default.
• W2064753657 hasLocation W20647536571 @default.
• W2064753657 hasOpenAccess W2064753657 @default.
• W2064753657 hasPrimaryLocation W20647536571 @default.
• W2064753657 isParatext "false" @default.
• W2064753657 isRetracted "false" @default.
• W2064753657 magId "2064753657" @default.
• W2064753657 workType "article" @default.